Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Total Liabilities : ¥1,729.5 Mil (As of Sep. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co Total Liabilities?

Beijing Bohui Innovation Biotechnology Group Co's Total Liabilities for the quarter that ended in Sep. 2024 was ¥1,729.5 Mil.

Beijing Bohui Innovation Biotechnology Group Co's quarterly Total Liabilities increased from Mar. 2024 (¥1,602.15 Mil) to Jun. 2024 (¥1,617.58 Mil) and increased from Jun. 2024 (¥1,617.58 Mil) to Sep. 2024 (¥1,729.54 Mil).

Beijing Bohui Innovation Biotechnology Group Co's annual Total Liabilities declined from Dec. 2021 (¥2,757.28 Mil) to Dec. 2022 (¥1,584.50 Mil) but then increased from Dec. 2022 (¥1,584.50 Mil) to Dec. 2023 (¥1,585.47 Mil).

Beijing Bohui Innovation Biotechnology Group Co Total Liabilities Historical Data

The historical data trend for Beijing Bohui Innovation Biotechnology Group Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Bohui Innovation Biotechnology Group Co Total Liabilities Chart

Beijing Bohui Innovation Biotechnology Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,642.46

2,290.17

2,757.28

1,584.50

1,585.47

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															1,533.32	1,585.47	1,602.15	1,617.58	1,729.54

Beijing Bohui Innovation Biotechnology Group Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Beijing Bohui Innovation Biotechnology Group Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1064.85	+	(380.418	+	140.202
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,585.5

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3926.015	-	2340.545
	=	1,585.5

Beijing Bohui Innovation Biotechnology Group Co's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1003.282	+	(588.939	+	137.319
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,729.5

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	4115.136	-	2385.596
	=	1,729.5

Beijing Bohui Innovation Biotechnology Group Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Beijing Bohui Innovation Biotechnology Group Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Bohui Innovation Biotechnology Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097

Website

http://www.bohui-tech.com

Beijing Bohui Innovation Biotechnology Group Co Ltd is a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. The company focuses on the research and development, production, sales, and after-sales services of in vitro diagnostic products. The Company's business involved two segments: inspection and testing and biological products. The Biological segment generated the majority of its revenue which engaged in the research and development, production, and sales of blood products, the product range covers human blood albumin, human immunoglobulin, and human coagulation factor three categories of multiple varieties, basically covering the important varieties of blood products.

Executives

Niu Shu Hui	Executives
Di Xiao Feng	Director
Yang Qi	Director
Lu Xin Qun	Directors, executives
Zhang Lei	Director
Wan Zhang Geng	Executives
Song Rui	Directors, executives

Beijing Bohui Innovation Biotechnology Group Co Headlines

No Headlines